Clinical Data, Inc.
Clinical Data, Inc. and Dana-Farber Cancer Institute Form Research Collaboration to Study Role of FCGR3A Gene Variants for Predicting Clinical Outcomes in Breast Cancer Treatment
Published in Cancer Weekly, June 2nd, 2009
PGxHealth, a division of Clinical Data, Inc. (NASDAQ: CLDA), announced that it has established a research collaboration with the Dana-Farber Cancer Institute (DCFI) to validate the use of genetic variants in Fc gamma receptors (FCGRs), including FCGR3A, in predicting response to trastuzumab (Herceptin) therapy in patients with breast cancer. The research, directed by Karen S. Anderson, M.D., Ph.D. at Dana-Farber, complements other studies underway to further demonstrate the contribution of genetic variants in the FCGR family to monoclonal antibody (mAb) response in cancer treatment. Importantly, the collaboration includes a large-scale effort to discover new genetic variants influencing...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2009-06-02)
More Articles from Cancer Weekly
- Allergies
Study data from National Institute of Allergy and Infectious Diseases update knowledge of allergies - Allos Therapeutics, Inc.
Allos Therapeutics Announces Updated Data from Pivotol Phase 2 PROPEL Study of Pralatrexate to be Presented at ASCO 2009 - Cancer Gene Therapy
New cancer gene therapy findings from University of Saskatchewan described - Cancer Gene Therapy
Reports outline cancer gene therapy study findings from University of Navarra - Cancer Gene Therapy
Research from Central South University has provided new information about cancer gene therapy - Cancer Gene Therapy
Research reports from University Hospital provide new insights into cancer gene therapy - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
